Eric Karas
Net worth: 73 056 $ as of 2026-08-30
Net worth: 73 056 $ as of 2026-08-30
Eric Karas is currently Chief Commercial Officer at ARS Pharmaceuticals Operations, Inc. since 2022.
Formerly, Mr. Karas was Vice President & General Manager-Commercial at Emergent BioSolutions, Inc. from 2018 to 2022.
Mr. Karas also served as Chief Commercial Officer at ARS Pharmaceuticals, Inc. from 2022 to 2026.
Education includes an undergraduate degree from Rutgers State University of New Jersey and an MBA from Eli Broad College of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-11 | 12,176 ( 0.01% ) | 73 056 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Corporate Officer/Principal | 2022-03-31 |
| Companies | Position | End |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2026-07-31 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 2022-02-28 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Eli Broad College of Business
Eli Broad College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Health Technology |
ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions